An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04744-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Stefanie Lietz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081, Ulm, Germ…. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin, Pertussis Toxin, Bordetella pertussis, Peptides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG, Deutsche Forschungsgemeinschaft, Universitätsklinikum Ulm.
Abstract (Originalsprache)
Pertussis, also known as whooping cough, is a highly infectious respiratory disease caused by the bacterium Bordetella pertussis . The bacterial virulence factor, pertussis toxin (PT), is associated with the manifestation of the characteristic symptoms of pertussis and the severe form of this disease. Increasing case numbers and the lack of treatment options highlight the need to develop novel pharmacological strategies, e.g., the generation of specific PT inhibitors. Recently, we identified the endogenous human protein α 1 -antitrypsin (α 1 AT) as an inhibitor of PT from a screening of a human hemofiltrate protein/peptide library. In the present work, we tested an in-house α 1 AT peptide bank to identify an α 1 AT region with anti-PT activity. Then, we compared the sequences of the positive hits from the peptide bank with all known α 1 AT fragments in the hemofiltrate samples to find new active peptides. In total, 36 peptides were tested for their PT inhibition, leading to the identification of an endogenous α 1 AT fragment, α 1 AT HF, derived from hemofiltrate with anti-PT activity. This peptide had no toxic effects on HeLa cells and in vivo on zebrafish embryos, rendering it an attractive lead compound for further evaluation to treat pertussis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081, Ulm, Germany.
- Core Facility Functional Peptidomics, Ulm University Medical Center, 89081, Ulm, Germany.
- Core Unit Mass Spectrometry and Proteomics, Ulm University Medical Center, 89081, Ulm, Germany.
- Institute of Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.
- Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
- Institute of Biomedicine, University of Turku, 20520, Turku, Finland.
Förderung
- DFG
- Deutsche Forschungsgemeinschaft
- Universitätsklinikum Ulm
Zitieren
APA
Lietz, S., Sokolowski, L. M., Beyschlag, A., Rosenau, H., Siewert, A., Alfonso, A. A. R., Preising, N., Ständker, L., Wiese, S., Köhler, J., Weidinger, G., Münch, J., Pulliainen, A. T., Ernst, K., & Barth, H. (2025). An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04744-1
Vancouver
Lietz S, Sokolowski LM, Beyschlag A, Rosenau H, Siewert A, Alfonso AAR, et al. An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04744-1
BibTeX
@article{Lietz2025,
author = {Lietz, Stefanie and Sokolowski, Lena-Marie and Beyschlag, Alexander and Rosenau, Helena and Siewert, Annika and Alfonso, Armando A Rodríguez and Preising, Nico and Ständker, Ludger and Wiese, Sebastian and Köhler, Janet and Weidinger, Gilbert and Münch, Jan and Pulliainen, Arto T and Ernst, Katharina and Barth, Holger},
title = {An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04744-1}
}
EUVIMED